Top Markets
#1 The Bitcoin Bull The Bitcoin Bull +33.12%
#2 DogBull DogBull +31.59%
#3 Siacoin Siacoin +27.39%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Ontology Gas Ontology Gas +21.33%
#6 Cash Cat Cash Cat +20.65%
#7 Pons Pons +19.03%
#8 MarsCoin MarsCoin +16.36%
#9 Akedo Akedo +11.45%
#10 Uniswap Uniswap +11.35%
Coin of the day
The Bitcoin Bull The Bitcoin Bull
設定
言語
日本
通貨
USD
テーマ
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
株式のランク #14551
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
株価
$0.87679425
最終同期: 2026-08-31
時価総額
$407.66M
変化（1日）
-1.88%
変化（1年）
58.03%
国
SE
取引 Egetis Therapeutics AB (publ) (EGTX)

カテゴリー

Healthcare
Egetis Therapeutics AB (publ)（EGTX）の収益
Sep 2026 時点の収益 TTM: 0
Egetis Therapeutics AB (publ) の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Egetis Therapeutics AB (publ) の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH